These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4800460)

  • 21. [Use of some immunodepressants and indocide in the therpay of diffuse glomerulonephritis in children].
    Odinets IuV; Basilaĭshvili VV
    Pediatr Akus Ginekol; 1975; (4):28-30. PubMed ID: 1228634
    [No Abstract]   [Full Text] [Related]  

  • 22. [Perspectives of indomethacin therapy in glomerular nephropathies].
    Vercellone A; Piccoli G; Ragni R; Cavalli PL
    Minerva Nefrol; 1969; 16(2):163-74. PubMed ID: 5398502
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunopathological bases of the treatment of glomerulonephritis].
    Vercellone A; Segoloni G; Stratta P; Coppo R; Triolo G; Messina M
    Minerva Med; 1978 Aug; 69(38):2611-24. PubMed ID: 152419
    [No Abstract]   [Full Text] [Related]  

  • 24. [Problems of clinical and morphological classification and observation of the course of glomerulonephritis. Initial results in long-term therapy].
    Krumhaar I; Reinschke P; Peschel HG; Otto F; Schwedtke H
    Dtsch Gesundheitsw; 1971 Feb; 26(8):333-41. PubMed ID: 5576672
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of a progressive nephropathy in rats by injections of human lung extract in Freund's complete adjuvant.
    Nagi AH; Barabas AZ
    J Pathol; 1972 Apr; 106(4):271-5. PubMed ID: 5046936
    [No Abstract]   [Full Text] [Related]  

  • 26. Nephritogenic glycoprotein. IV. Induction of proliferative glomerulonephritis with immunofluorescent "mesangial pattern" in rats by a single injection of heterologous renal glycoprotein.
    Shibata S; Nagasawa T
    Immunology; 1974 Apr; 26(4):855-63. PubMed ID: 4604811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic woman with massive proteinuria and acute renal failure.
    Nair R; Said M
    Am J Kidney Dis; 2005 Aug; 46(2):362-6. PubMed ID: 16112058
    [No Abstract]   [Full Text] [Related]  

  • 28. Mercuric chloride-induced glomerulopathy in BN-rats: application to preclinical drug testing.
    Hermann P; Poschmann G; Bolliger S; Meyer D; Schuurman HJ
    Transplant Proc; 1993 Oct; 25(5):2826-7. PubMed ID: 8212249
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic possibilities in chronic glomerulonephritis].
    Brass H
    Munch Med Wochenschr; 1969 Aug; 111(35):1759-66. PubMed ID: 5820240
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic glomerulonephritis in rats immunized with species homologous placental antigens.
    Boss JH; Silber E; Nelken D
    Pathol Eur; 1968; 3(4):602-15. PubMed ID: 4973790
    [No Abstract]   [Full Text] [Related]  

  • 31. Proteinuria and nonsteroid anti-inflammatory drugs.
    Michielsen P; Varenterghem Y
    Adv Nephrol Necker Hosp; 1983; 12():139-50. PubMed ID: 6404132
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced experimental autoimmune nephritis.
    Druet P; Baran D; Pelletier L; Hirsch F; Druet E; Sapin C
    Concepts Immunopathol; 1986; 3():311-30. PubMed ID: 3297328
    [No Abstract]   [Full Text] [Related]  

  • 33. [CONTRIBUTION TO THE SUBJECT OF AUTOIMMUNE NEPHROPATHY: EXPERIMENTAL AUTOIMMUNE NEPHROPATHY IN THE RAT].
    NAVA C; CARAMIA G; AGNOLUCCI MT; CARLINI G
    Arch Sci Med (Torino); 1964 Dec; 118():353-77. PubMed ID: 14269263
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum beta-1C globulin levels in persistent glomerulonephritis with low serum complement: variability unrelated to clinical course.
    West CD; McAdams AJ
    Nephron; 1970; 7(3):193-202. PubMed ID: 5442623
    [No Abstract]   [Full Text] [Related]  

  • 35. Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.
    Dotremont G; Vermylen J; Donati MB; Van Damme B; Michielsen P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):829-44. PubMed ID: 4803317
    [No Abstract]   [Full Text] [Related]  

  • 36. Minimal change lesion with nephrotic syndrome and focal glomerular sclerosis. (Variations of minimal proliferative intercapillary glomerulonephritis with the nephrotic syndrome).
    Bohle A; Fischbach H; Wehner H; Woerz U; Edel HH; Kluthe R; Scheler F
    Clin Nephrol; 1974; 2(2):52-8. PubMed ID: 4830512
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental autoimmune glomerulonephritis in chickens.
    Bolton WK; Tucker FL; Sturgill BC
    J Clin Lab Immunol; 1980 May; 3(3):179-84. PubMed ID: 7420406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of glomerulonephritis with indomethacin and heparin.
    Suc JM; Conte J; Mignon-Conte
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):927-47. PubMed ID: 4803319
    [No Abstract]   [Full Text] [Related]  

  • 39. [Histological course of diffuse proliferative glomerulonephritis treated with indomethacin].
    Michielsen P; Verberckmoes R; Desmet V; Hermerijckx W
    J Urol Nephrol (Paris); 1969; 75(4):315-8. PubMed ID: 5370830
    [No Abstract]   [Full Text] [Related]  

  • 40. [The mechanism of action of immunomodulating preparations ( an analysis of their therapeutic effect in a model of experimental cardiomyopathy].
    Groppa LG; Kobets VA; Andreev IuL
    Revmatologiia (Mosk); 1991; (3):30-2. PubMed ID: 1812560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.